Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Califf Nomination Advances; Opponents Push Opioids Fight

This article was originally published in Scrip

Executive Summary

The Senate on Feb. 22 voted 80-6 to move forward with considering Robert Califf as the next commissioner of the FDA – defeating two holds placed on his nomination by Sens. Edward Markey (D-MA) and Bernie Sanders (I-VT) and stifling any chance of a filibuster, which Sen. Joe Manchin (D-WV) had threatened to pursue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register